ersodetug
ersodetug: sourced relationships with 1 company · 1 clinical trial tracked.
ersodetug evidence translation
What we can confirm
1 tracked trial
What it means
What to watch
Prepared research question
How could ersodetug → RZLT affect its developer, and what evidence supports the link?
Traceable citations · Unknowns marked
See linked entities and source evidence1 indications · 0 study sponsors
Related indications
Study sponsors
No additional listed-company sponsor is linked.
Dated Pipeline Records (1)
| Company | Dated record stage |
|---|---|
| Rezolute, Inc. (RZLT) Tumor Hyperinsulinism (Tumor HI) | Phase 3 |
Clinical Trial Registry Records (1)
A Phase 3, Single-Arm, Open-label, Pivotal Study to Evaluate the Efficacy and Safety of Ersodetug Compared to Baseline in Patients With Inadequately Controlled Hypoglycemia Due to Tumor Hyperinsulinism (Tumor HI)
Primary endpoint: Proportion of participants with clinically meaningful reduction in IV glucose infusion rate from baseline.
Frequently asked questions
Which companies have sourced relationships with ersodetug?
ersodetug has dated SEC/FDA relationship records for Rezolute, Inc..
How many clinical trials involve ersodetug?
BioSniper tracks 1 clinical trial involving ersodetug.